These effects are dose-dependent, meaning the faster the medication hits your system, the more pronounced they may be during the initial absorption phase
These include semaglutide, tirzepatide, oral semaglutide, and orforglipron, each working through the GLP-1 pathway to suppress appetite and support sustainable weight loss
Clinical trials show patients lose 1020% of body weight over 612 months a magnitude of loss previously achievable only with bariatric surgery
Healthcare providers should discuss realistic expectations about weight maintenance after stopping and develop comprehensive strategies to minimize weight regain
The date on the label is typically the Beyond-Use Date for an unopened, sterile vial
Add methylmalonic acid if B12 levels are borderline